Pathogens chipping away at our last line of defence – the rise of the metallo-beta-lactamases
We describe the first known report of a VIM1 metallo-beta-lactamase-producing Klebsiella pneumonia outside Europe – confirmed by our colleagues in Canada. The patient had no travel history and surveillance failed to identify additional cases. The importance of health care professionals being diligent in identifying these multi-drug resistant isolates is emphasised.
Johan Moolman, Lancet Laboratories
Klebsiella, VIM, metallo-B-lactamase
Cite this article
South African Medical Journal 2012;102(1):27.
Date submitted: 2011-11-02
Date published: 2011-12-14
Abstract views: 1411
Full text views: 1965
Comments on this article
*Read our policy for posting comments here